Patents by Inventor Philip Rybczynski

Philip Rybczynski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted fused heterocyclic C-glycosides
    Patent number: 7094763
    Abstract: This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: August 22, 2006
    Assignee: Janssen Pharaceutica, N.V.
    Inventors: Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang
  • Treating syndrome X with substituted tetralins and indanes
    Publication number: 20060094786
    Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
    Type: Application
    Filed: June 3, 2005
    Publication date: May 4, 2006
    Inventors: Xiaoli Chen, Keith Demarest, Jung Lee, Jay Matthews, Philip Rybczynski
  • Methods of using substituted tetralins and indanes
    Publication number: 20060074130
    Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
    Type: Application
    Filed: June 3, 2005
    Publication date: April 6, 2006
    Inventors: Xiaoli Chen, Keith Demarest, Jung Lee, Jay Matthews, Philip Rybczynski
  • Substituted indole-O-glucosides
    Publication number: 20050037981
    Abstract: Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 17, 2005
    Inventors: Mary Beavers, Mona Patel, Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang
  • Substituted fused heterocyclic C-glycosides
    Publication number: 20050037980
    Abstract: This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 17, 2005
    Inventors: Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang
  • Substituted indazole-O-glucosides
    Publication number: 20050032711
    Abstract: Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 10, 2005
    Inventors: Mona Patel, Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang
  • Treating Syndrome X with substituted tetralins and indanes
    Publication number: 20040171680
    Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
    Type: Application
    Filed: October 17, 2003
    Publication date: September 2, 2004
    Inventors: Xiiaoli Chen, Keith T. Demarest, Jung Lee, Jay M. Matthews, Philip Rybczynski
  • Methods of using substituted tetralins and indanes
    Publication number: 20040167211
    Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
    Type: Application
    Filed: October 17, 2003
    Publication date: August 26, 2004
    Inventors: Xiiaoli Chen, Keith T. Demarest, Jung Lee, Jay M. Matthews, Philip Rybczynski
  • Treating syndrome X with substituted tetralins and indanes
    Publication number: 20040162352
    Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
    Type: Application
    Filed: October 17, 2003
    Publication date: August 19, 2004
    Inventors: Xiaoli Chen, Keith T. Demarest, Jung Lee, Jay M. Matthews, Philip Rybczynski